PeerVoice Oncology & Haematology Video artwork

PeerVoice Oncology & Haematology Video

306 episodes - English - Latest episode: about 1 month ago - ★★★★★ - 1 rating

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science medical education peervoice oncology haematology hematology cancer
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Episodes

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

November 29, 2021 23:00 - 1 hour Video

Taking Check of Advanced Non-Melanoma Skin Cancers: Exploring the Clinical Impact of Systemic Immunotherapies

Strategies to Improve Quality of Life in Patients With MDS: Translating the Evidence With Oral HMAs to Practice

November 18, 2021 23:00 - 13 minutes Video

Strategies to Improve Quality of Life in Patients With MDS: Translating the Evidence With Oral HMAs to Practice

Can We Afford Not To? Optimizing Use of G-CSF Biosimilars in Supportive Cancer Care in Canada

November 10, 2021 23:00 - 17 minutes Video

Can We Afford Not To? Optimizing Use of G-CSF Biosimilars in Supportive Cancer Care in Canada

Practice Essentials for Improving Outcomes in Waldenstrom Macroglobulinemia

October 26, 2021 23:00 - 7 minutes Video

Practice Essentials for Improving Outcomes in Waldenstrom Macroglobulinemia

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

October 26, 2021 23:00 - 5 minutes Video

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights from 2021 Virtual Congresses

The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care

October 21, 2021 23:00 - 1 hour Video

The Need for Speed: Improving Diagnostic Accuracy and Effective Management of aTTP in Emergency and Intensive Care

Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them

October 21, 2021 23:00 - 26 minutes Video

Seeking a More Positive Outlook in Patients With mTNBC? Treatment Advances and How to Apply Them

The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal

October 21, 2021 23:00 - 20 minutes Video

The Cancer No One Wants to Talk About: Squamous Cell Carcinoma of the Anal Canal

Anti–CD38-Based Regimens for Relapsed/Refractory Multiple Myeloma: Expert Perspectives on the Latest Evidence

October 14, 2021 23:00 - 17 minutes Video

Anti–CD38-Based Regimens for Relapsed/Refractory Multiple Myeloma: Expert Perspectives on the Latest Evidence

An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?

October 06, 2021 23:00 - 42 minutes Video

An Immune System in Double Trouble: What Is ‘Best Practice’ for Managing Patients With Lymphoproliferative Malignancies?

Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action

September 21, 2021 23:00 - 20 minutes Video

Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action

Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment

September 20, 2021 23:00 - 10 minutes Video

Make It a Double? Expert Insights on the Role of Dual Immunotherapy Regimens in First-Line NSCLC Treatment

Improving Outcomes in Non-Metastatic CRPC: Case by Case

August 18, 2021 23:00 - 19 minutes Video

Improving Outcomes in Non-Metastatic CRPC: Case by Case

Treatment Perspectives in HER2-Positive Advanced Breast Cancer: The Role of Novel Therapies in Pretreated Patients

July 30, 2021 23:00 - 10 minutes Video

Treatment Perspectives in HER2-Positive Advanced Breast Cancer: The Role of Novel Therapies in Pretreated Patients

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses

July 26, 2021 23:00 - 9 minutes Video

Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses

A Case in Point: Navigating the Differential Diagnosis of aHUS in Clinical Practice

July 22, 2021 23:00 - 8 minutes Video

A Case in Point: Navigating the Differential Diagnosis of aHUS in Clinical Practice

Fortifying the Treatment of Prostate Cancer With AR-Targeted Therapy: Solidifying Clinical Guidance With Practical Evidence

July 22, 2021 23:00 - 14 minutes Video

Fortifying the Treatment of Prostate Cancer With AR-Targeted Therapy: Solidifying Clinical Guidance With Practical Evidence

What's on the Radio? 2021 Data Broadcast on Radioligands in Men With CRPC

July 21, 2021 23:00 - 19 minutes Video

What's on the Radio? 2021 Data Broadcast on Radioligands in Men With CRPC

Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?

July 12, 2021 23:00 - 58 minutes Video

Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?

Navigating the Evolving Therapeutic Landscape of RRMM: Expert Insights on the Latest Advances

June 28, 2021 23:00 - 21 minutes Video

Navigating the Evolving Therapeutic Landscape of RRMM: Expert Insights on the Latest Advances

Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?

June 25, 2021 23:00 - 26 minutes Video

Checkpoint Inhibitors for Advanced or Recurrent Endometrial Cancer: A New Standard of Care?

Treating Anemia in Low- to Intermediate-Risk MDS: Translating the Latest Science into Patient Care

June 25, 2021 23:00 - 12 minutes Video

Treating Anemia in Low- to Intermediate-Risk MDS: Translating the Latest Science into Patient Care

Radioligand Therapy in mCRPC: A Team Effort

June 24, 2021 23:00 - 28 minutes Video

Radioligand Therapy in mCRPC: A Team Effort

Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold

June 21, 2021 23:00 - 59 minutes Video

Advanced Basal Cell Carcinoma: An Exploration of Clinical Challenges and What the Future Could Hold

Strategies to Maximize Long-Term Outcomes in Patients With Chronic Lymphocytic Leukemia (CLL)

June 18, 2021 23:00 - 7 minutes Video

Strategies to Maximize Long-Term Outcomes in Patients With Chronic Lymphocytic Leukemia (CLL)

Making Treatment of Unresectable HCC Personal: How Individualized Approaches Can Maximize Outcomes

June 16, 2021 23:00 - 16 minutes Video

Making Treatment of Unresectable HCC Personal: How Individualized Approaches Can Maximize Outcomes

"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"

June 11, 2021 23:00 - 13 minutes Video

"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"

Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care

June 11, 2021 23:00 - 9 minutes Video

Evaluating the Role of Oral Hypomethylating Agents in MDS: Considerations to Optimize Care

Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do

June 11, 2021 23:00 - 13 minutes Video

"Improving Outcomes in Early-Stage EGFR-Mutant NSCLC: What Pathologists Can Do"

From Bench to Bedside: Evaluating the Role of Maintenance Therapy to Improve Outcomes in Patients With AML

May 28, 2021 23:00 - 15 minutes Video

From Bench to Bedside: Evaluating the Role of Maintenance Therapy to Improve Outcomes in Patients With AML

Optimizing Care for Unresectable Malignant Pleural Mesothelioma: Challenges and Solutions

May 24, 2021 23:00 - 8 minutes Video

Optimizing Care for Unresectable Malignant Pleural Mesothelioma: Challenges and Solutions

Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer

May 20, 2021 23:00 - 27 minutes Video

Asked and Answered: Differentiating Between PARP Inhibitors in First-Line Advanced Ovarian Cancer

Cases in Patient-Centred Care of ITP: Expert Guidance to Optimize Diagnosis and Treatment

May 14, 2021 23:00 - 15 minutes Video

Cases in Patient-Centred Care of ITP: Expert Guidance to Optimize Diagnosis and Treatment

Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

May 11, 2021 23:00 - 16 minutes Video

Evolving Treatment Paradigm in Early-Stage EGFR-Mutant NSCLC: A Primer for Medical Oncologists

Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

May 10, 2021 23:00 - 19 minutes Video

Best Practices in Early-Stage EGFR-Mutant NSCLC: A Primer for Radiation Oncologists

Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

May 07, 2021 23:00 - 26 minutes Video

Improving Outcomes in Localised EGFR-Mutant NSCLC: Perspectives for Pulmonologists

Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?

April 30, 2021 23:00 - 19 minutes Video

Could PSMA Be the ‘Bulls-Eye’ Target in mCRPC?

Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy

April 21, 2021 23:00 - 28 minutes Video

Is It the Carrot or the Stick? Practical Strategies for Improving Adherence to Antidiabetic Therapy

Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting

April 08, 2021 23:00 - 14 minutes Video

Addressing Challenges in Lung Cancer Patient Management From Diagnosis to Treatment in a Community Setting

Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk

March 17, 2021 23:00 - 23 minutes Video

Opportunistic Invasive Fungal Infections: Proactive Diagnosis of Patients at Risk

Metastatic Urothelial Carcinoma: Maintaining Stable Disease

March 08, 2021 23:00 - 16 minutes Video

Metastatic Urothelial Carcinoma: Maintaining Stable Disease

PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes

March 05, 2021 23:00 - 16 minutes Video

PARP Inhibitors for Recurrent Ovarian Cancer: Leveraging the Latest Tools in the Therapeutic Toolbox to Improve Patient Outcomes

Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors

March 01, 2021 23:00 - 10 minutes Video

Prevention and Management of Cardiovascular Adverse Events in Multiple Myeloma: Safe and Appropriate Use of Proteasome Inhibitors

"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "

February 26, 2021 23:00 - 43 minutes Video

"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "

Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria

February 26, 2021 23:00 - 43 minutes Video

"Complementing Evidence With Expert Experience: Challenging Cases in Paroxysmal Nocturnal Haemoglobinuria "

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments

February 24, 2021 23:00 - 16 minutes Video

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments

When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC

February 22, 2021 23:00 - 20 minutes Video

When Physics Fuses With Medicine: A New Therapeutic Modality for mCRPC

Basal Cell Carcinoma: Treatment Advances for the Progressing Patient

February 19, 2021 23:00 - 13 minutes Video

Basal Cell Carcinoma: Treatment Advances for the Progressing Patient

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

February 17, 2021 23:00 - 19 minutes Video

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!

Seizing the Moment to Improve Outcomes in Melanoma: When and in Whom Should We Consider Adjuvant Therapy?

February 15, 2021 23:00 - 13 minutes Video

Seizing the Moment to Improve Outcomes in Melanoma: When and in Whom Should We Consider Adjuvant Therapy?